RecruitingNot ApplicableNCT04043598

Crystalloid Fluid Choice and Neurological Outcome in Patients After Subarachnoid Haemorrhage

Crystalloid Fluid Choice and Neurological Outcome in Patients After Subarachnoid Haemorrhage - a Multi-center Randomized Double-blind Clinical Trial


Sponsor

Insel Gruppe AG, University Hospital Bern

Enrollment

320 participants

Start Date

May 24, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

Patients with subarachnoid hemorrhage are prone to suffer from dysnatriemia. Evidence shows that hyponatriemia is associated with increased incidence of vasospasm, brain swelling and mortality in these patients. Patients with subarachnoid hemorrhage often require large amounts of iv fluids in order to maintain euvolemia and support cardiocirculatory function. Prior evidence shows that the type of infusion fluid significantly influences blood sodium content. Hence, this study evaluated whether the sodium content of the infusion solution impacts mortality and morbidity in patients with subarachnoid hemorrhage.


Eligibility

Min Age: 16 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called 0.9% Sodium-chloride and a drug called Ringer's Lactate for people with critical illness, infusion fluid, and other related conditions. The study is currently recruiting participants at 3 locations. People eligible for this study include aged 16 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUG0.9% Sodium-chloride

We will compare two already established treatment protocols: the use of normal saline versus lactated Ringer's for fluid therapy in patients with subarachnoid hemorrhage.

DRUGRinger's Lactate

We will compare two already established treatment protocols: the use of normal saline versus lactated Ringer's for fluid therapy in patients with subarachnoid hemorrhage.


Locations(3)

Department of perioperative Intensive Care Medicine

Sankt Gallen, Canton of St. Gallen, Switzerland

Department of Intensive Care, Bern University Hospital and University of Bern, Bern, Switzerland

Bern, Switzerland

Department of Intensive Care Medicine

Geneva, Switzerland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04043598


Related Trials